Literature DB >> 29152504

Hypertension highlights during 2016.

Wilbert S Aronow1.   

Abstract

Entities:  

Year:  2017        PMID： 29152504      PMCID： PMC5673795          DOI： 10.21037/atm.2017.07.42

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  19 in total

Review 1.  Treatment of Hypertension in Patients with Coronary Artery Disease. A Case-Based Summary of the 2015 AHA/ACC/ASH Scientific Statement.

Authors:  Clive Rosendorff
Journal:  Am J Med       Date:  2015-12-02       Impact factor: 4.965

2.  What Should the Optimal Systolic Blood Pressure Goal Be in Treating Older Persons with Hypertension?

Authors:  Wilbert S Aronow
Journal:  J Am Med Dir Assoc       Date:  2016-05-20       Impact factor: 4.669

3.  The SPRINT and the HOPE-3 Trial in the Context of Other Blood Pressure-Lowering Trials.

Authors:  Salim Yusuf; Eva Lonn
Journal:  JAMA Cardiol       Date:  2016-11-01       Impact factor: 14.676

4.  Comparing the SPRINT and the HOPE-3 Blood Pressure Trial.

Authors:  Paul K Whelton; David M Reboussin; Lawrence J Fine
Journal:  JAMA Cardiol       Date:  2016-11-01       Impact factor: 14.676

Review 5.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

6.  The Cardiovascular Risk of White-Coat Hypertension.

Authors:  Stanley S Franklin; Lutgarde Thijs; Kei Asayama; Yan Li; Tine W Hansen; José Boggia; Lotte Jacobs; Zhenyu Zhang; Masahiro Kikuya; Kristina Björklund-Bodegård; Takayoshi Ohkubo; Wen-Yi Yang; Jørgen Jeppesen; Eamon Dolan; Tatiana Kuznetsova; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Jan Filipovský; Yutaka Imai; Ji-Guang Wang; Eoin O'Brien; Jan A Staessen
Journal:  J Am Coll Cardiol       Date:  2016-11-08       Impact factor: 24.094

7.  Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control.

Authors:  John W McEvoy; Yuan Chen; Andreea Rawlings; Ron C Hoogeveen; Christie M Ballantyne; Roger S Blumenthal; Josef Coresh; Elizabeth Selvin
Journal:  J Am Coll Cardiol       Date:  2016-08-30       Impact factor: 24.094

8.  Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention.

Authors:  Nancy R Cook; Lawrence J Appel; Paul K Whelton
Journal:  J Am Coll Cardiol       Date:  2016-10-11       Impact factor: 24.094

9.  Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Authors:  Eva M Lonn; Jackie Bosch; Patricio López-Jaramillo; Jun Zhu; Lisheng Liu; Prem Pais; Rafael Diaz; Denis Xavier; Karen Sliwa; Antonio Dans; Alvaro Avezum; Leopoldo S Piegas; Katalin Keltai; Matyas Keltai; Irina Chazova; Ron J G Peters; Claes Held; Khalid Yusoff; Basil S Lewis; Petr Jansky; Alexander Parkhomenko; Kamlesh Khunti; William D Toff; Christopher M Reid; John Varigos; Lawrence A Leiter; Dora I Molina; Robert McKelvie; Janice Pogue; Joanne Wilkinson; Hyejung Jung; Gilles Dagenais; Salim Yusuf
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

Review 10.  Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.

Authors:  Xinfang Xie; Emily Atkins; Jicheng Lv; Alexander Bennett; Bruce Neal; Toshiharu Ninomiya; Mark Woodward; Stephen MacMahon; Fiona Turnbull; Graham S Hillis; John Chalmers; Jonathan Mant; Abdul Salam; Kazem Rahimi; Vlado Perkovic; Anthony Rodgers
Journal:  Lancet       Date:  2015-11-07       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.